The U.S. has unveiled a new healthy eating icon called MyPlate, to replace the older and more controversial food pyramid.
Tag: breast cancer treatment
FDA Revokes Approval for Avastin as Breast Cancer Treatment
n June, an FDA advisory committee recommended that Avastin’s approval be revoked, citing evidence that suggests the drug has limited effectiveness in metastatic breast cancer, but that it dramatically raises the risk of life-threatening side effects.
Breast Cancer Risk Varies Among Women Taking Menopausal Hormones
Menopausal hormone use or hormone replacement therapy (HRT) has been associated with an increased risk of breast cancer, but this risk varies depending on a woman’s race, body mass index (BMI) and breast density, according to the results of a …
WHI Trial Suggests Possible Reduction in Breast Cancer Risk with Estrogen Alone
Postmenopausal women who take hormone therapy consisting of estrogen alone may have a somewhat reduced risk of breast cancer. These findings—from longer term follow up of the Women’s Health Initiative trial of estrogen alone—were published in the Journal of the …
MRI Detects Earlier-stage Breast Cancers among Women with BRCA1/2 Mutations
Annual breast cancer screening that includes magnetic resonance imaging (MRI) reduces the frequency of advanced breast cancers among women with a BRCA1 or BRCA2 mutation. These results were published in the Journal of Clinical Oncology. Inherited mutations in two genes—BRCA1 …
Diagnosis of Early Breast Cancer Doesn’t Shorten Life Expectancy of Older Women
Among women age 67 or older, a diagnosis of ductal carcinoma in situ (DCIS) or Stage I breast cancer doesn’t appear to worsen survival survival is similar to that of older women without breast cancer. Diagnosis of more advanced breast …
Breast Cancer Rates No Longer Declining
After a sharp decline in breast cancer rates between 2002 and 2003 among non Hispanic white women in the US, overall breast cancer rates did not change significantly between 2003 and 2007. These results were published in Cancer Epidemiology, Biomarkers, …
Halaven Improves Survival with Metastatic Breast Cancer
Among women with previously treated, locally recurrent or metastatic breast cancer, treatment with the chemotherapy drug Halaven™ (eribulin mesylate) improved overall survival by 2.5 months. The results of this Phase III clinical trial were published in The Lancet. Metastatic breast …
Mammography Less Accurate for Detection of Second Cancers
Among women with a personal history of breast cancer, mammography can detect second cancers at an early stage, but may be less accurate than among women who have never had breast cancer. These results were published in the Journal of …
Obesity Linked with Triple-Negative Breast Cancer
Women who are obese and not physically active may be more likely than other women to develop triple negative breast cancer (breast cancer that is estrogen receptor negative, progesterone receptor negative, and HER2 negative). These results were published in Cancer …